Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial (2018)
Attributed to:
Development of MRI-guided radiation therapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ctro.2018.08.003
PubMed Identifier: 30386824
Publication URI: http://europepmc.org/abstract/MED/30386824
Type: Journal Article/Review
Parent Publication: Clinical and Translational Radiation Oncology
ISSN: 2405-6308